These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 15157250)
1. Persistence of cefotetan on red blood cells. Davenport RD; Judd WJ; Dake LR Transfusion; 2004 Jun; 44(6):849-52. PubMed ID: 15157250 [TBL] [Abstract][Full Text] [Related]
2. Clinical and laboratory study of an episode of cefotetan-induced severe hemolytic anemia. Franchini M; Piccoli PL; Gandini G; Giuffrida A; Bressan F; De Gironcoli M; Aprili G Hematology; 2004 Feb; 9(1):65-9. PubMed ID: 14965871 [TBL] [Abstract][Full Text] [Related]
3. Cross-reactivity of cefotetan and ceftriaxone antibodies, associated with hemolytic anemia, with other: cephalosporins and penicillin. Arndt PA; Garratty G Am J Clin Pathol; 2002 Aug; 118(2):256-62. PubMed ID: 12162687 [TBL] [Abstract][Full Text] [Related]
4. Serology of antibodies to second- and third-generation cephalosporins associated with immune hemolytic anemia and/or positive direct antiglobulin tests. Arndt PA; Leger RM; Garratty G Transfusion; 1999; 39(11-12):1239-46. PubMed ID: 10604252 [TBL] [Abstract][Full Text] [Related]
5. Fatal immune hemolytic anemia due to cefotetan. Garratty G; Nance S; Lloyd M; Domen R Transfusion; 1992; 32(3):269-71. PubMed ID: 1557811 [TBL] [Abstract][Full Text] [Related]
6. The first case of drug-induced immune hemolytic anemia due to hydrocortisone. Martinengo M; Ardenghi DF; Tripodi G; Reali G Transfusion; 2008 Sep; 48(9):1925-9. PubMed ID: 18565121 [TBL] [Abstract][Full Text] [Related]
7. Cefotetan-induced immune hemolytic anemia following prophylaxis for cesarean delivery. Shariatmadar S; Storry JR; Sausais L; Reid ME Immunohematology; 2004; 20(1):63-6. PubMed ID: 15373671 [TBL] [Abstract][Full Text] [Related]
8. Positive direct and indirect antiglobulin tests associated with oxaliplatin can be due to drug antibody and/or drug-induced nonimmunologic protein adsorption. Arndt P; Garratty G; Isaak E; Bolger M; Lu Q Transfusion; 2009 Apr; 49(4):711-8. PubMed ID: 19192254 [TBL] [Abstract][Full Text] [Related]
17. Delayed hemolytic transfusion reaction in sickle cell disease patients: evidence of an emerging syndrome with suicidal red blood cell death. Chadebech P; Habibi A; Nzouakou R; Bachir D; Meunier-Costes N; Bonin P; Rodet M; Chami B; Galacteros F; Bierling P; Noizat-Pirenne F Transfusion; 2009 Sep; 49(9):1785-92. PubMed ID: 19413729 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of potential immune response and in vivo survival of riboflavin-ultraviolet light-treated red blood cells in baboons. Goodrich RP; Murthy KK; Doane SK; Fitzpatrick CN; Morrow LS; Arndt PA; Reddy HL; Buytaert-Hoefen KA; Garratty G Transfusion; 2009 Jan; 49(1):64-74. PubMed ID: 18954398 [TBL] [Abstract][Full Text] [Related]
19. The production of red blood cell alloantibodies in mice transfused with blood from transgenic Fyb-expressing mice. Campbell-Lee SA; Liu J; Velliquette RW; Halverson GR; Shirey RS; Chaudhuri A; Reid ME; Ness PM; Baldwin WM Transfusion; 2006 Oct; 46(10):1682-8. PubMed ID: 17002623 [TBL] [Abstract][Full Text] [Related]
20. Passenger lymphocyte syndrome with or without immune hemolytic anemia in all Rh-positive recipients of lungs from rhesus alloimmunized donors: three new cases and a review of the literature. Cserti-Gazdewich CM; Waddell TK; Singer LG; Chaparro C; Pendergrast JM; Hawes J; denHollander N; Tinckam K; Keshavjee S Transfus Med Rev; 2009 Apr; 23(2):134-45. PubMed ID: 19304114 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]